![Echocardiography-Guided Risk Stratification for Long QT Syndrome - Congenital Heart International Professionals (CHiP) Network Echocardiography-Guided Risk Stratification for Long QT Syndrome - Congenital Heart International Professionals (CHiP) Network](https://uv0pl4on9b-flywheel.netdna-ssl.com/wp-content/uploads/2021/03/table-description-automatically-generated-3.png)
Echocardiography-Guided Risk Stratification for Long QT Syndrome - Congenital Heart International Professionals (CHiP) Network
![Risk Prediction in Women With Congenital Long QT Syndrome | Journal of the American Heart Association Risk Prediction in Women With Congenital Long QT Syndrome | Journal of the American Heart Association](https://www.ahajournals.org/cms/asset/0c061206-6dd3-4714-b09d-1b25870a2568/jah36436-fig-0002.png)
Risk Prediction in Women With Congenital Long QT Syndrome | Journal of the American Heart Association
Challenges and opportunities for integrating genetic testing into a diagnostic workflow: heritable long QT syndrome as a model
Independent validation and clinical implications of the risk prediction model for long QT syndrome (1-2-3-LQTS-Risk)
![A Primary Prevention Clinical Risk Score Model for Patients With Brugada Syndrome (BRUGADA-RISK) | JACC: Clinical Electrophysiology A Primary Prevention Clinical Risk Score Model for Patients With Brugada Syndrome (BRUGADA-RISK) | JACC: Clinical Electrophysiology](https://www.jacc.org/cms/asset/0d93f3d6-e203-42dd-8b41-91387026dbdd/fx1.jpg)
A Primary Prevention Clinical Risk Score Model for Patients With Brugada Syndrome (BRUGADA-RISK) | JACC: Clinical Electrophysiology
![Interplay Between Genetic Substrate, QTc Duration, and Arrhythmia Risk in Patients With Long QT Syndrome - ScienceDirect Interplay Between Genetic Substrate, QTc Duration, and Arrhythmia Risk in Patients With Long QT Syndrome - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0735109718332546-fx1.jpg)
Interplay Between Genetic Substrate, QTc Duration, and Arrhythmia Risk in Patients With Long QT Syndrome - ScienceDirect
![Frontiers | Ranolazine as an Alternative Therapy to Flecainide for SCN5A V411M Long QT Syndrome Type 3 Patients Frontiers | Ranolazine as an Alternative Therapy to Flecainide for SCN5A V411M Long QT Syndrome Type 3 Patients](https://www.frontiersin.org/files/Articles/580481/fphar-11-580481-HTML-r2/image_m/fphar-11-580481-g001.jpg)
Frontiers | Ranolazine as an Alternative Therapy to Flecainide for SCN5A V411M Long QT Syndrome Type 3 Patients
![PDF] The long QT syndrome: a transatlantic clinical approach to diagnosis and therapy. | Semantic Scholar PDF] The long QT syndrome: a transatlantic clinical approach to diagnosis and therapy. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/d9bd950af1b76f7d06da535e9f17f17f7f0daeb0/3-Table1-1.png)
PDF] The long QT syndrome: a transatlantic clinical approach to diagnosis and therapy. | Semantic Scholar
![Risk Stratification of Type 2 Long-QT Syndrome Mutation Carriers With Normal QTc Interval | Circulation: Arrhythmia and Electrophysiology Risk Stratification of Type 2 Long-QT Syndrome Mutation Carriers With Normal QTc Interval | Circulation: Arrhythmia and Electrophysiology](https://www.ahajournals.org/cms/asset/68c7e3fd-f38d-4e97-97f2-f44c181c6536/e005918fig05.jpg)
Risk Stratification of Type 2 Long-QT Syndrome Mutation Carriers With Normal QTc Interval | Circulation: Arrhythmia and Electrophysiology
Transethnic Genome-Wide Association Study Provides Insights in the Genetic Architecture and Heritability of Long QT Syndrome
![Non-Invasive Electrophysiological Markers Associated With Long QT Syndrome - Ardashev - Cardiac Arrhythmias Non-Invasive Electrophysiological Markers Associated With Long QT Syndrome - Ardashev - Cardiac Arrhythmias](https://journals.eco-vector.com/public/journals/117/homepageImage_ru_RU.png)